We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00612612
Recruitment Status : Terminated
First Posted : February 11, 2008
Last Update Posted : September 30, 2013
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : July 2013
  Study Completion Date : No date given